Business Inquiry
Global:
Email:marketing@medicilon.com
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
China:
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
Killing tumors induced by mediated immune cells; Blocking dual target signal, exerting unique or repetitive functions, effectively preventing drug resistance; Greater specificity, targeting ability, and reduced off-target toxicity, effective reduction of treatment costs.